IPP Bureau
UFlex partners with Hoffer Plastics and Mespack to launch recyclable mono-polymer hot fill pouches
By IPP Bureau - September 30, 2021
These pouches, manufactured at UFlex India plant, will be exported to American markets and will be majorly used for packing edible products
Roche launches cobas pure integrated solutions analyser
By IPP Bureau - September 30, 2021
Cobas pure provides clinical labs with access to more than 230 diagnostic tests across a wide range of disease areas including infectious diseases, oncology and cardiology
Lupin launches Droxidopa capsules in the US
By IPP Bureau - September 29, 2021
Droxidopa capsules, 100 mg, 200 mg, and 300 mg is a generic equivalent of Northera capsules, 100 mg, 200 mg, and 300 mg, of Lundbeck NA
Apollo Hospitals dedicates AI tool to predict cardiovascular disease to the nation
By IPP Bureau - September 29, 2021
Cardiovascular disease is the leading cause of death in the Asia Pacific, and it's a problem that will only intensify as populations continue to age
Fortis Hospital conducts complex surgery to save a patient with recurrent heart failure
By IPP Bureau - September 29, 2021
A team of experts at Fortis Gurugram conducted 3-dimensional mapping with the help of the new system Carto version 7 to precisely map the source of the arrhythmia. It was detected that the arrhythmia was coming from the conduction system i.e. body’s natural wiring.
Morpen Labs carves out diagnostics business to unlock value
By IPP Bureau - September 29, 2021
The new devices company will scale up its teams to create a world-class R&D centre for medical devices in India
Dr Reddy’s creates world’s largest toothbrush sculpture
By IPP Bureau - September 29, 2021
Fastminar is a 40-feet structure made with approximately 80,000 toothbrushes and is located at Terna Dental College in Navi Mumbai
Thermo Fisher launches SpeciMAX saliva collection kit
By IPP Bureau - September 29, 2021
The kit preserves viral nucleic acids in a non-hazardous stabilization solution that inactivates common respiratory viruses for safer sample collection
Shalby Hospitals teams up with Ganpat university to offer MBA in healthcare management
By IPP Bureau - September 29, 2021
The aspirant can enrol in MBA (Healthcare and Hospital Management) at Ganpat University, -Centre for Management Studies and Research, which will be facilitated by Ganpat University and Shalby Centre for Healthcare Management and Research
MSD India launches 9-valent Human Papillomavirus (HPV) vaccine, GARDASIL 9
By IPP Bureau - September 29, 2021
India’s first gender-neutral HPV vaccine to help reduce HPV -related disease burden in Indian girls, women and boys
Digital health-start-up MFine raises US $ 48 million
By IPP Bureau - September 29, 2021
Since its inception, over three million users have used MFine services with the platform clocking over three lakh monthly transactions
Zebra Medical Vision receives clearance for Coronary Artery Calcium (CAC) solution
By IPP Bureau - September 28, 2021
The CAC solution cleared by the U.S. FDA analyses already existing non-gated CT scans and quantifies the coronary artery calcium in order to identify, stratify, and facilitate treatment pathways for patients with cardiovascular disease
Eisai initiates rolling submission for Biological Licence Application of Lecanemab
By IPP Bureau - September 28, 2021
The BLA is being submitted under the accelerated approval pathway and is primarily based on clinical, biomarker and safety data from the Phase 2b clinical trial in people with early AD and confirmed amyloid pathology
Positive results from Lynparza with abiraterone delays Metastatic prostrate cancer
By IPP Bureau - September 28, 2021
Prostate cancer is the second-most common cancer in men and despite an increase in the number of available treatments for men with mCRPC, five-year survival remains low
Cardiovascular devices market to grow at a CAGR of 3.9 % up to 2027
By IPP Bureau - September 28, 2021
One of the key factors driving the market growth is the rise in the occurrence of chronic cardiovascular diseases such as heart failure and coronary artery disease: Valuates Reports
